You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for World Intellectual Property Organization (WIPO) Patent: 2006085838


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for World Intellectual Property Organization (WIPO) Patent: 2006085838

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Jan 31, 2028 Cubist Pharms Llc DIFICID fidaxomicin
⤷  Start Trial Jan 31, 2028 Cubist Pharms Llc DIFICID fidaxomicin
⤷  Start Trial Sep 4, 2027 Cubist Pharms Llc DIFICID fidaxomicin
⤷  Start Trial Jan 31, 2028 Cubist Pharms Llc DIFICID fidaxomicin
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of WIPO Patent WO2006085838: Scope, Claims, and Patent Landscape

Last updated: October 9, 2025


Introduction

Patent WO2006085838, filed under the World Intellectual Property Organization (WIPO) system, represents a crucial piece of intellectual property within the pharmaceutical domain. As a WIPO international application, it aims to secure patent protection across multiple jurisdictions, signaling significant commercial and therapeutic interest. This analysis dissects the patent's scope, claims, and the broader patent landscape, providing insight into its strategic implications for stakeholders in pharmaceutical innovation, patent law, and market competition.


Overview of WO2006085838

Published on August 17, 2006, WO2006085838 pertains to a novel pharmaceutical compound, composition, or method—specifics that can be ascertained from its claims and description sections. While the exact chemical entities or therapeutic targets are not explicitly available here, typical WIPO applications of this nature focus on innovative drug candidates, formulations, or delivery mechanisms.

The patent application follows the standard structure with an abstract, detailed description, claims, and drawings (if applicable). Its primary purpose is to secure exclusive rights for the invention globally, facilitating a competitive advantage upon granting.


Scope of the Patent

The scope of WO2006085838 hinges on the breadth of its claims. It aims to encompass:

  1. Chemical Entities: Novel compounds with defined structural features.
  2. Pharmaceutical Compositions: Incorporating the inventive compounds into formulations suitable for therapeutic use.
  3. Therapeutic Methods: Specific methods of treating diseases or conditions using the claimed compositions.
  4. Manufacturing Processes: Methods for synthesizing or formulating the compounds.

The patent likely employs both independent and dependent claims, with independent claims outlining the core inventive concepts and dependent claims specifying particular embodiments, auxiliary features, or narrower scopes.

Claim Types and Strategies

  • Compound Claims: Cover the core chemical entities. These are typically broad, aiming to capture all relevant analogs within the defined chemical space.
  • Use Claims: Cover therapeutic applications or methods of treatment.
  • Formulation Claims: Cover specific delivery systems, excipients, or controlled-release mechanisms.
  • Process Claims: Cover synthesis or manufacturing techniques.

The scope's breadth depends heavily on the claim language; narrower claims limit risk of invalidation but offer weaker protection, whereas broader claims increase infringement risk but could face validity challenges due to prior art.


Claims Analysis

Without the specific claim language, general principles apply:

  • Breadth vs. Specificity:

    • Broad claims may encompass a wide spectrum of compounds or methods, providing extensive coverage.
    • Narrow claims focus on particular compounds or therapeutic indications, reducing the risk of invalidity but limiting coverage.
  • Key Elements in Claims:

    • Structural Features: Define the chemical core or substituents.
    • Functional Limitations: Specify therapeutic activity or property.
    • Method Steps: Detail treatment or synthesis procedures.
  • Potential Patentability Challenges:

    • Novelty: Must distinguish from prior art.
    • Inventive Step: Demonstrate non-obviousness over existing compounds/methods.
    • Utility: Confirmed therapeutic or industrial application.

The overall strength of the patent will depend significantly on the specificity and innovation level articulated in these claims.


Patent Landscape

The patent landscape surrounding WO2006085838 involves:

1. Prior Art Analysis

  • Pre-existing Compounds: Similar molecules or classes might challenge novelty.
  • Related Patents: Patent families protecting similar chemical or therapeutic space could influence scope.
  • Publications: Scientific literature revealing prior compounds or methods.

Identifying overlaps informs the scope of potential patentability and enforcement.

2. Patent Families and Priority

  • The application likely has priority claims to earlier filings, possibly in the applicant’s home country, establishing a filing date across jurisdictions.
  • Subsequent patent families may exist within national or regional patent offices, extending protection.

3. Patent Filing Strategies

  • Multinational corporations often file such applications to secure a broad, international shield.
  • Focused applications may target key markets where the compound or method has commercial potential (e.g., US, EU, China).

4. Potential Infringements and Litigation

  • The broadness of claims can provoke infringement disputes in markets where the patent grants enforceable rights.
  • Patentability challenges or oppositions may arise if prior art is deemed to undermine novelty or inventive step.

5. Competitive Landscape

  • Identification of similar patents reveals competitors' R&D focus.
  • Licensing or cross-licensing opportunities may emerge from overlapping patent rights.

Key players in this landscape include large pharmaceutical companies seeking to protect innovative molecules, academic institutions holding foundational patents, and biotech firms exploring niche therapeutic areas.


Legal and Commercial Implications

  • Patent Validity: Ensuring claims are sufficiently supported and distinct over prior art.
  • Freedom to Operate (FTO): Evaluating whether other patents restrict commercialization.
  • Market Exclusivity: Effective patent enforcement can secure market share and recoup R&D investments.
  • Regulatory Pathways: Patent rights complement regulatory approval processes, influencing market entry strategies.

Strategic recommendations include conducting comprehensive patent landscaping, monitoring competitor patent filings, and preparing for potential oppositions or patent infringements.


Conclusion

WO2006085838 exemplifies a strategic patent application designed to secure broad protection on innovative pharmaceutical entities. The specificity of its claims underpins its strength, affecting how effectively it can block competitors and safeguard investment. Its position within the patent landscape depends heavily on prior art, claim drafting, and jurisdictional filings.

A robust understanding of its scope and claims enables patent holders and licensees to navigate legal uncertainties, enforce rights, and plan meaningful commercialization pathways.


Key Takeaways

  • The scope of WO2006085838 is primarily defined by its claims; broad claims offer extensive protection but face higher validity scrutiny.
  • The patent landscape includes prior art, related patent families, and market competitors; thorough landscaping is essential.
  • Strategic patent drafting and filing across jurisdictions maximize protection and market control.
  • Enforcement and defense depend on clear, distinct claims with strong novelty and inventive step.
  • Regular landscape monitoring supports proactive IP management, licensing opportunities, and competitive positioning.

FAQs

1. What is the significance of WO2006085838 being a WIPO application?
It indicates the applicant’s intent to seek patent protection internationally, leveraging the Patent Cooperation Treaty (PCT) process to streamline filings across multiple jurisdictions.

2. How do the claims in this patent influence its enforceability?
Claims define the scope of protection; well-drafted, specific claims provide clear boundaries, making enforcement and defense more straightforward.

3. Can similar compounds be patented if they differ slightly from the claims?
Yes; modifications that do not fall within the scope of the claims can sometimes be patented separately, provided they meet patentability criteria.

4. How does the patent landscape affect research and development?
Understanding existing patents helps R&D teams avoid infringement, identify licensing opportunities, and guide innovation.

5. What are the main challenges in patenting pharmaceutical compounds like those in WO2006085838?
Challenges include demonstrating novelty amid existing literature, establishing non-obviousness, and drafting claims broad enough to protect proprietary interests without being vulnerable to invalidation.


References

[1] World Intellectual Property Organization. WO2006085838 patent publication. Retrieved from WIPO PATENTSCOPE database.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.